Your selection
Research, Innovation, Patient care, Education / 18.09.2025
Talk in the Cube: IP STRATEGIES IN BIOTECHNOLOGY
We are excited to continue the Talks in the Cube with an expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology.
Effective strategies for Intellectual Property (IP) in Biotechnology include using patents for new processes and products, applying trade secrets for complex bioengineering methods, and employing trademarks for branding. A comprehensive strategy also means building adequate patent portfolios through patent jungles or "Biobetters", monitoring and defending IP rights against infringement, and potentially using licensing agreements for technology transfer.
Our two esteemed experts who are trained natural scientists AND European Patent Attorneys. They will share their insights and experiences with us.
A Panel Discussion with
Dr. Sun Jin Lee, European Patent Attorney, European Patent Litigator (UPC), Maiwald GmbH, Munich
Dr. Oliver Ladendorf, LL.B., European Patent Attorney, Kraus & Lederer PartGmbH, Munich
Dr. Uwe Lohmeier, Berlin BioScience Academy (BBA), Campus Berlin Buch GmbH (Moderation).
Topics planned to be addressed
- Smart patenting for Biotech: Portfolios providing leverage and attracting investors
- Licensing of innovative technologies: Patents for organoids and CRISPR/Cas
- Biotech Patents and AI: Examples to influence innovations and to protect data-driven discoveries.
The talk will be followed by a networking event where you can socialize over snacks and drinks.
Target audience
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions.
Costs
Participation is free of charge. Registration is requested.
When
Thursday, 18 September 2025
5:00 p.m. - 7:00 p.m.
Where
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin
Quelle: BerlinBioscience Academy
Further information and registration
Overview News
News Buch Berlin
Eckert & Ziegler: Strong FY 2025 with Positive Outlook
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) set a new record in fiscal year 2025 with sales of €312.0 million. Compared to the previous year, sales rose by approximately €16 million (+5%).
more ...Launch of the Einstein Center for Early Disease Interception
At the Einstein Center for Early Disease Interception, researchers from twelve Berlin institutions will be pooling their expertise to explore new approaches to prevention, long before symptoms appear,...
more ...Strengthen international cooperation in clinical trials
As part of the Australian Clinical Trials Initiative, ACTI, Australian companies and representatives of the Australien Government’s Trade and Invest Commission, Austrade, visited the Berlin-Buch Scien...
more ...Events Buch Berlin
11.04.2026, 10:00
Geführte Wanderung durch das Stadtgut und den Schlosspark in Buch
Manfred Pinkwart lädt ein
more ...16.04.2026, 09:00
Gläsernes Labor - Unsichtbare Welten: Mikroplastik in Mensch und Natur
Vorbeikommen und mitmachen: Spannende Experimentierkurse für Kids und Megamikroskopie im Zeiss-Großplanetarium
more ...16.04.2026, 09:00
Career Day 2026: “Transition Possible: Explore Careers on Campus Buch”
Are you considering your next career step as a scientist? On April 16, the Career Day at Campus Buch invites to explore possible career paths beyond academia, hearing from professionals who have made ...
more ...